Transradial versus transfemoral intervention in ST-segment elevation myocardial infarction patients in Korean population = Transradial versus transfemoral intervention in ST-segment elevation myocardial infarction patients in Korean population

다국어 초록 (Multilingual Abstract)

Background/Aims: Transradial intervention (TRI) is becoming the preferred method over transfemoral intervention (TFI) because TRI is associated with lower incidence of major bleeding and vascular complications. However, there has been limited published data regarding the clinical outcomes of TRI versus TFI in Korean patients with ST-elevation myocardial infarction (STEMI).
Methods: A total of 689 consecutive STEMI patients who underwent primary percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) from January to December of 2009 at nine university hospitals were enrolled in this study. Mid-term angiographic and 12-month cumulative clinical outcomes of the TRI group (n = 220, 31.9%) were compared to those of the TFI group (n = 469, 28.1%).
Results: After propensity score matching, in-hospital complications and the 12-month major clinical outcomes during follow-up in the two groups were similar to each other. However, the incidence rates of repeat revascularization (6.4% vs. 0.5%, p = 0.003), target vessel revascularization (6.4% vs. 0.5%, p = 0.003), and major adverse cardiac events (MACE; 11.6% vs. 4.6%, p = 0.018) in the TFI group were higher than those in the TRI group during the 12-month of follow-up.
Conclusions: In our study, TRI in STEMI patients undergoing primary PCI with DESs was associated with lower incidence of access site hematoma, 12-month repeat revascularization, and MACE compared to TFI. Therefore, TRI might play an important role in reducing bleeding complications while improving major clinical outcomes in STEMI patients undergoing primary PCI with DESs.

참고문헌 (Reference)

1 Byrne RA, "Vascular access and closure in coronary angiography and percutaneous intervention" 10 : 27-40, 2013

2 Mehran R, "Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium" 123 : 2736-2747, 2011

3 Bernat I, "ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial" 63 : 964-972, 2014

4 Romagnoli E, "Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study" 60 : 2481-2489, 2012

5 Agostoni P, "Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials" 44 : 349-356, 2004

6 Jolly SS, "Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials" 157 : 132-140, 2009

7 Jolly SS, "Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial" 307 : 1409-1420, 2011

8 Oweida SW, "Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty" 12 : 310-315, 1990

9 Nasser TK, "Peripheral vascular complications following coronary interventional procedures" 18 : 609-614, 1995

10 Wolfe MW, "Length of hospital stay and complications after percutaneous transluminal coronary angioplasty: clinical and procedural predictors. Heparin Registry Investigators" 92 : 311-319, 1995

11 Kinnaird TD, "Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions" 92 : 930-935, 2003

12 Ellis SG, "In-hospital cost of percutaneous coronary revascularization: critical determinants and implications" 92 : 741-747, 1995

13 Mehta SR, "Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation" 60 : 2490-2499, 2012

14 Cooper CJ, "Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison" 138 : 430-436, 1999

15 Jolly SS, "Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial" 6 : 258-266, 2013

16 Delarche N, "Direct angioplasty for acute myocardial infarction in elderly patients using transradial approach" 8 : 32-35, 1999

17 Saito S, "Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial" 59 : 26-33, 2003

18 Cutlip DE, "Clinical end points in coronary stent trials: a case for standardized definitions" 115 : 2344-2351, 2007

19 Yatskar L, "Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry" 69 : 961-966, 2007

20 Kiemeneij F, "A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study" 29 : 1269-1275, 1997